LRP2 was highly expressed in cancers that arise from absorptive epithelia, such as clear cell renal cell carcinoma, papillary renal cell carcinoma, mesothelioma, invasive breast carcinoma, and papillary thyroid cancer. Here, LRP2 is linked to thyroid gland papillary carcinoma.